Michael E. Kamarck Vaxcyte, Inc. (PCVX) insider trading activity

Michael E. Kamarck is Director of Vaxcyte, Inc.. Currently has a direct ownership of 5,625 shares of PCVX, which is worth approximately $455,456. The most recent transaction as insider was on Jun 13, 2023, when has been sold 2,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.63K

0% 3M change

0% 12M change

Total Value Held $455,456

Michael E. Kamarck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 13 2023	BUY Grant, award, or other acquisition	-	2,500 Added 30.77%	5,625 Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	3,125 Added 50.0%	3,125 Common Stock

Also insider at

PASG

Passage BIO, Inc. Healthcare

Director

MEK